# Bemiparin Randomized Trial on Bridging Oral Anticoagulants in Invasive Procedures (BERTA Study)

> **NCT00484822** · PHASE3 · TERMINATED · sponsor: **Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau** · enrollment: 206 (actual)

## Conditions studied

- Long-term Oral Anticoagulant Therapy

## Interventions

- **DRUG:** Bemiparina Sodica
- **DRUG:** Heparina Cálcica

## Key facts

- **NCT ID:** NCT00484822
- **Lead sponsor:** Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-02
- **Primary completion:** —
- **Final completion:** 2009-05
- **Target enrollment:** 206 (ACTUAL)
- **Why stopped:** The study has been halted prematurely due to a low recruitment.
- **Last updated:** 2010-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00484822

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00484822, "Bemiparin Randomized Trial on Bridging Oral Anticoagulants in Invasive Procedures (BERTA Study)". Retrieved via AI Analytics 2026-08-01 from https://api.ai-analytics.org/clinical/NCT00484822. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*